"Companies and stakeholders across the energy spectrum need to act together and act fast." Photo via Getty Images

Houston is home to some of the nation's largest oil and gas exploration and production firms, making it one of the world’s most important energy capitals. Growing regional support for pioneering clean tech, such as carbon capture, will help achieve the crucial transition to net zero whilst maintaining economic stability, boosting local industries and creating jobs.

According to the International Energy Agency (IEA), North America and Asia Pacific are expected to hold the largest share in carbon capture capacity. North America’s world-leading carbon capture potential comes as no surprise given the nation’s dominance in oil and gas, and ideal geology for sequestration.

The IEA’s recently published World Energy Outlook 2023 depicts a global market that is in transition. With more companies, world leaders and governments recognizing that a shift towards sustainable energy is both inevitable and transformative, the question is no longer whether we switch to clean energy, but rather how soon the transition can happen.

For every $1 in investment spending on fossil fuels globally, $1.8 is now being spent to develop clean energy, according to the IEA. Although the clean energy market has almost doubled in the past five years to reach an estimated $2.8 trillion in 2023, investment needs to hit $4.2 trillion per year by 2030 to achieve the universally shared goal of net zero. The IEA believes around 1 Gigaton of CO2 must be captured in 2030, rising to 6 Gigatons by 2050 to achieve the Net Zero Emissions by 2050 Scenario (termed NZE Scenario). This presents a tremendous opportunity for government stakeholders and the business community in Houston to turbocharge the economy and protect the planet from the impact of climate change.

While volatility around the energy market lingers, sustainable technologies remain one of the most dynamic areas of global energy investment. An essential ingredient to its success is bringing on board innovators, entrepreneurs, corporations, and financiers to ensure technology innovation is front and center in facilitating the clean energy transition.

Carbon capture technology is critical, but energy leaders and hard-to-abate industries are under pressure to move faster. To do that, the carbon capture industry must scale up its deployment and increase adoption if hard-to-abate sectors are to address the 30 percent of global CO2 emissions for which they are responsible. Governments have a pivotal role to play in providing financial, regulatory and policy incentives, facilitating a collaborative environment between financiers, hard-to-abate operators, and clean tech companies. While we are moving in the right direction, there is no room for complacency or procrastination given the short timescales for meaningful action.

Over the past several years, Carbon Clean, a global company that is revolutionizing carbon capture, has enjoyed significant expansion in North America. Following the passage of the Inflation Reduction Act (IRA) in August 2022, we saw huge interest in our modular industrial carbon capture technology almost overnight, resulting in a 64 percent increase in inquiries from the U.S. To meet this booming demand, we have opened a U.S. headquarters in Houston, and have plans to double our U.S. headcount to meet industry requirements for our scalable and cost-effective technology, CycloneCC. In short, the United States is poised to become our biggest market. Given our latest lead investor and partner is Houston-based Chevron New Energies, there is no better place than Houston to drive innovation in the country’s energy sector.

The IRA did more than just bring in new inquiries for our breakthrough technology – it also signaled to the energy sector that the federal government is getting serious about bringing emissions down. The impact of the IRA cannot be overstated, especially for the point-source carbon capture technology pioneered by Carbon Clean. While the IRA involves billions of dollars of public investment, it is set up in such a way that companies must make substantial investments first, acting as a down payment on fostering jobs and ensuring the business community is delivering ambitious climate action. The benefits are being felt locally as well – cities like Houston are at the forefront of what the IRA has to offer, taking advantage of these investments and reducing emissions.

Companies and stakeholders across the energy spectrum need to act together and act fast. With the dramatic growth required for carbon capture to have full effect, it will be essential for government, industry, and innovators to join together to concentrate on a number of projects and clusters. We are confident that with new cutting-edge technology and broad collaboration we can rapidly get the world on the right path to net zero.

———

Prateek Bumb is CTO and co-founder of Carbon Clean and the principal innovator of Carbon Clean’s industrial carbon capture technologies.

This article originally ran on EnergyCapital.
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Nominations are now open for the 2025 Houston Innovation Awards

Calling All Innovators

Calling all Houston innovators: The Houston Innovation Awards return this fall to celebrate the best and brightest in the Houston innovation ecosystem right now.

Presented by InnovationMap, the fifth annual Houston Innovation Awards will take place November 5 at TMC Helix Park.

The awards program will honor the top startups and innovators in Houston across 10 categories, and we're asking you to nominate the most deserving Houston innovators and innovative companies today.

This year's categories are:

  • Minority-founded Business, honoring an innovative startup founded or co-founded by BIPOC or LGBTQ+ representation.
  • Female-founded Business, honoring an innovative startup founded or co-founded by a woman.
  • Energy Transition Business, honoring an innovative startup providing a solution within renewables, climatetech, clean energy, alternative materials, circular economy, and beyond.
  • Health Tech Business, honoring an innovative startup within the health and medical technology sectors.
  • Deep Tech Business, honoring an innovative startup providing technology solutions based on substantial scientific or engineering challenges, including those in the AI, robotics, and space sectors.
  • Startup of the Year (People's Choice), honoring a startup celebrating a recent milestone or success. The winner will be selected by the community via an interactive voting experience.
  • Scaleup of the Year, honoring an innovative later-stage startup that's recently reached a significant milestone in company growth.
  • Incubator/Accelerator of the Year, honoring a local incubator or accelerator that is championing and fueling the growth of Houston startups.
  • Mentor of the Year, honoring an individual who dedicates their time and expertise to guide and support budding entrepreneurs.
  • Trailblazer, honoring an innovator who's made a lasting impact on the Houston innovation community.

Nominations may be made on behalf of yourself, your organization, and other leaders in the local innovation scene. The nomination period closes on August 31, so don't delay — nominate today at this link, or fill out the embedded form below.

Our panel of esteemed judges will review the nominations, and determine the finalists and winners. Finalists will be unveiled on September 30, and the 2025 Houston Innovation Awards winners will be announced live at our event on November 5.

Tickets will go on sale this fall. Stay tuned for that announcement, as well as more fanfare leading up to the 2025 Houston Innovation Awards.

Nominate now:

Interested in Innovation Awards sponsorship opportunities? Please contact sales@innovationmap.com.

MD Anderson launches $10M collaboration to advance personalized cancer treatment tech

fighting cancer

The University of Texas MD Anderson Cancer Center and Japan’s TOPPAN Holdings Inc. have announced a strategic collaboration to co-develop TOPPAN Holdings’ 3D cell culture, or organoid, technology known as invivoid.

The technology will be used as a tool for personalized cancer treatments and drug screening efforts, according to a release from MD Anderson. TOPPAN has committed $10 million over five years to advance the joint research activities.

“The strategic alliance with MD Anderson paves a promising path toward personalized cancer medicine," Hiroshi Asada, head of the Business Innovation Center at TOPPAN Holdings, said in a news release.

Invivoid is capable of establishing organoid models directly from patient biopsies or other tissues in a way that is faster and more efficient. Researchers may be able to test a variety of potential treatments in the laboratory to understand which approach may work best for the patient, if validated clinically.

“Organoids allow us to model the three-dimensional complexity of human cancers in the lab, thus allowing us to engineer a powerful translational engine—one that could not only predict how patients will respond to therapy before treatment begins but also could help to reimagine how we discover and validate next-generation therapies," Dr. Donna Hansel, division head of pathology and laboratory medicine at MD Anderson, added in the news release. “Through this collaboration, we hope to make meaningful progress in modeling cancer biology for therapeutic innovation.”

The collaboration will build upon preclinical research previously conducted by MD Anderson and TOPPAN. The organizations will work collaboratively to obtain College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments (CLIA) certifications for the technology, which demonstrate a commitment to high-quality patient care. Once the certifications are obtained, they plan to conduct observational clinical studies and then prospective clinical studies.

“We believe our proprietary invivoid 3D cell culture technology, by enabling the rapid establishment of organoid models directly from patient biopsies, has strong potential to help identify more effective treatment options and reduce the likelihood of unnecessary therapies,” Asada added in the release. “Through collaboration on CAP/CLIA certification and clinical validation, we aim to bring this innovation closer to real-world patient care and contribute meaningfully to the advancement of cancer medicine."